(19)
(11) EP 4 583 847 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23771796.2

(22) Date of filing: 07.09.2023
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/4422(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/2054; A61K 9/2059; A61K 9/205; A61K 9/2027; A61K 9/2018; A61K 31/4422
(86) International application number:
PCT/EP2023/074658
(87) International publication number:
WO 2024/052498 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 07.09.2022 DE 102022003339

(71) Applicant: Kinast, Lasse
10963 Berlin (DE)

(72) Inventor:
  • Kinast, Lasse
    10963 Berlin (DE)

(74) Representative: Kilger, Ute 
Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22
80336 München
80336 München (DE)

   


(54) AN IMMEDIATE-RELEASE ORAL PHARMACEUTICAL FORM OF AMLODIPINE WITH INCREASED API CONTENT